BackEupraxia Pharmaceuticals Overview
Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Discounted Cash Flow

DCF Analysis for EPRX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$1.44

Current Fair Value

$1.44
76.2% Downside

Overvalued by 76.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading